Abstract
Objectives: The aim of this study was to identify the molecular defect in a group of 37 unrelated Greek Cypriot patients affected by NC-CAH and evaluate the relationship between the genotype, phenotype and adrenal androgen levels. Design and methods: Clinical evaluation, biochemical analysis of 17-OHP, Testosterone, Androstenedione, DHEA-S, direct DNA sequencing and MLPA analyses. Results: Eleven known mutations were identified with the p.V281L being the most predominant and observed in 68.9% of the alleles. There was no difference between the two genotypes (mild/mild and mild/severe) with clinical presentation, whereas a proportional relationship between the type of mutation and adrenal androgen levels was found. Conclusion: The frequency of the underlying genetic defect in our patients with NC-CAH is similar to that observed in most Mediterranean populations. Although the genotype cannot solely explain the clinical expression of NC-CAH, discrimination between mild and severe alleles is crucial in antenatal diagnosis and genetic counselling.
| Original language | English |
|---|---|
| Pages (from-to) | 959-963 |
| Number of pages | 5 |
| Journal | Clinical Biochemistry |
| Volume | 44 |
| Issue number | 12 |
| DOIs | |
| Publication status | Published - Aug 2011 |
Keywords
- 17-OHP
- CYP21A2
- Increment4
- NC-CAH
- Testosterone
Fingerprint
Dive into the research topics of 'Endocrine profile and phenotype-genotype correlation in unrelated patients with non-classical congenital adrenal hyperplasia'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver